Ascom Acquires the Italian Medical Software Company UMS

AscomAscom has acquired the Italian software company UMS (United Medical Software), which provides integrations for medical devices and supplies digital medical records software solutions for life-critical patient care. With the acquisition of UMS, Ascom will gain access to new software and competence for global integrated workflow solutions in Healthcare ICT. Moreover, Ascom will improve its market position in Italy significantly thanks to the UMS installed base.

UMS s.r.l. is a privately held medical software company based in the region of Florence. The company delivers modular, point-of-care, digital medical records software solutions for life-critical patient care. UMS solutions help clinicians treat patients facing life-critical outcomes, while filing the gaps in digital medical records technology. UMS offers more than 200 medical device integrations and 1,000 different EMR forms and integrations. UMS' customers include large university hospitals, private specialty clinics, and healthcare government entities. UMS has products ready for international deployment and installations in Europe. The Company produces CE-marked medical device software, and is a partner/supplier of large companies in the medical device business.

UMS has a well-established installed base, mainly in the Italian market, and is expected to achieve revenues in the range of EUR 3-4 million in 2015, with EBITDA margins comparable to the Ascom Wireless Solutions Division.

With this acquisition, Ascom will gain access to new software and additional competence for global integrated workflow solutions in Healthcare ICT. Ascom will leverage the acquired software solutions globally. Consequently, capabilities to integrate medical devices and therefore mission-critical data into existing Ascom workflow solutions and Ascom Myco will be increased. In addition, Ascom will be granted access to new solutions for intensive care and surgical workflow management in high acuity units. Finally, the acquisition will help Ascom reach previously underserved geographical areas and increase its market share in Italy and Southern Europe. The acquisition fits perfectly with Ascom’s strategy for achieving its 2020 ambitions.

Ascom signed an agreement to acquire all shares of the company UMS s.r.l. Closing is expected to take place in mid-January 2016. All 27 employees will be taken over at their existing location. The purchase price amounts to the mid-single digit millions in CHF. In addition, Ascom has agreed to an earn-out payment in the low-single digit millions in CHF, dependent on the achievement of agreed revenue targets.

Gabriele Unterberger, who founded and successfully led UMS, will continue to run the company, to be renamed "Ascom UMS s.r.l.", as its Managing Director.

"Ascom is very pleased to have acquired a business with such a good strategic fit. This is an important technology acquisition for Ascom’s Healthcare ICT strategy. With the acquired software solutions, we have the opportunity to give our customers even more possibilities to improve their clinical workflows. In addition, we will gain direct access to the Italian market. This transaction accelerates Ascom’s roadmap for its integration capabilities and is the next step in building and strengthening the leading position of Wireless Solutions in the global healthcare communications market," underlines Claes Ödman, General Manager Ascom Wireless Solutions.

About Ascom
Ascom is an international solutions provider with comprehensive know-how in healthcare workflows and telecommunications. The company is active in Wireless Solutions (an international market leader for high-value, customer-specific on-site communication solutions and workflow optimization) and Network Testing (a global market leader in testing, monitoring, post processing, and performance optimization for mobile networks). The Ascom Group is headquartered in Switzerland, has subsidiaries in 19 countries and employs around 1,700 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

UK PACS Win for Carestream Announced

West Hertfordshire Hospitals NHS Trust (West Herts) located in the South East of the UK and Carestream have signed and exchanged contracts to replace the Trust's existing PACS with a...